Coriell Institute for Medical Research has announced the appointed of David Friedman, president of RSI; Calvin Knowlton, M.Div., Ph.D., founder, CEO and chairman of RevolutionCare, Inc.; and Brian Litten, vice president, strategic and external affairs, AmeriHealth New Jersey, to its board of trustees. The new members will serve three-year renewable terms.
"We are extremely pleased to add to the board a distinguished group of business professionals who bring to Coriell a wealth of diverse experience and capabilities," said Peter Driscoll, chairman of the board of trustees. "These highly accomplished individuals will enhance our ability to advance Coriell’s Personalized Medicine Collaborative (CPMC), a research study that explores the use of personal genome information in clinical decision-making.”